Hironori Yoshiyama

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba et al. · Nature Immunology · 2012 · 812 citations · Full text

Cancer Immunosurveillance, Receptor Tim-3, Immunology +12

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Masahisa Jinushi, Shigeki Chiba, Hironori Yoshiyama et al. · Proceedings of the National Academy of Sciences · 2011 · 476 citations · Full text

Tumor-associated Macrophages, Immunology, Biological Microenvironments +16

Exosomes Derived from Epstein-Barr Virus-Infected Cells Are Internalized via Caveola-Dependent Endocytosis and Promote Phenotypic Modulation in Target Cells

Asuka Nanbo, Eri Kawanishi, Ryuji Yoshida et al. · Journal of Virology · 2013 · 339 citations · Full text

Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21

Hironori Yoshiyama, S Imai, Norio Shimizu et al. · Journal of Virology · 1997 · 145 citations · Full text

Cancer-associated Virus, New Virus Receptor, Medicine +15

TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance

Muhammad Baghdadi, Akihiro Yoneda, Tsunaki Yamashina et al. · Immunity · 2013 · 128 citations · Full text